Hunan Jingfeng Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 611.82 million compared to CNY 559.77 million a year ago. Revenue was CNY 611.82 million compared to CNY 559.77 million a year ago.

Net loss was CNY 29.76 million compared to net income of CNY 14.66 million a year ago. Basic loss per share from continuing operations was CNY 0.0338 compared to basic earnings per share from continuing operations of CNY 0.0167 a year ago. Diluted loss per share from continuing operations was CNY 0.0338 compared to diluted earnings per share from continuing operations of CNY 0.0167 a year ago.